Ethereum-listed company Huajian Medical acquires a 3.142 billion HKD stake in Guofu Quantum to advance its RWA exchange strategy

ChainCatcher news, according to the Hong Kong Stock Exchange announcement, Hong Kong Ethereum treasury listed company Huajian Medical announced the acquisition of 20.31% equity in Guofu Quantum for approximately HKD 3.142 billion to advance its RWA exchange strategy. The transaction will be paid through the issuance of consideration shares, with an issue price of HKD 9.69 per share.

Upon completion of the acquisition, Huajian Medical will become the major shareholder of Guofu Quantum and will incorporate it into its financial statements using the equity method. This acquisition is part of Huajian Medical's strategy to promote the RWA (Real World Asset) exchange, achieving a closed-loop ecosystem from the asset side to the trading side, and will lay out plans in the stablecoin market. In August of this year, Huajian Medical announced the official launch of a global enhanced Ethereum treasury strategy with a downside protection mechanism, positioning Ethereum as its core reserve asset.